Market Place

11 Apr 2017

A leading biopharmaceutical corporation dedicated to developing, manufacturing and commercializing quality branded generics across the Middle East and Africa (MEA) is searching for licensors (with supply) of Celecoxib injection and Vitamin D injection 100,000 to 600,000 IU, and for Ceftaroline injection, Perindopril tablets under technology transfer or dossier acquisition model. The quantity forecast can be discussed later with the potential licensor.

Like

Comments (1)

View

0

1

Copyright © 2017 LePro PharmaCompass OPC Private Limited, All rights reserved.